M&A Deal Summary |
|
|---|---|
| Date | 2025-06-04 |
| Target | Harbor Global |
| Sector | Business Services |
| Buyer(s) | BayPine |
| Deal Type | Buyout (LBO, MBO, MBI) |
| Advisor(s) | Baird Marks Baughan Jamieson Corporate Finance (Financial) DLA Piper Morgan Lewis (Legal) |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 2019 |
| PE ASSETS | 3.0B USD |
| Size | Large |
| Type | Sector Agnostic |
BayPine is a private investment firm that seeks to invest in and acquire market-leading businesses across traditional sectors of the economy. BayPine has a particular interest in businesses where digital transformation can have a big impact on the future growth. BayPine was formed in 2020 and is headquartered in Boston, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 7 of 7 |
| Sector: Business Services M&A | 1 of 1 |
| Type: Buyout (LBO, MBO, MBI) M&A Deals | 1 of 1 |
| State: Illinois M&A | 1 of 1 |
| Country: United States M&A | 7 of 7 |
| Year: 2025 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2025-04-14 |
CenExel
Salt Lake City, Utah, United States CenExel is a clinical research site manager primarily conducting studies in post-op pain, neurology and psychiatry on behalf of pharmaceutical companies. The Company offers study services spanning from patient recruitment and screening/enrollment, to medical procedures and monitoring. CenExel was formed in 2018 and is based in Salt Lake City, Utah. |
Buy | - |
